France’s Sanofi and Britain’s GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults. The announcement is a huge setback in efforts to fight the pandemic, which first emerged in China last December and has killed over 1.5 million people worldwide. Sanofi and GSK said the delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme was to “improve immune response in older adults.” The vaccine’s potential availability had been pushed back “from mid-2021 to Q4 2021,” they said in a statement. American pharmaceutical giant Pfizer and its German partner BioNTech have said
Hence then, the article about sanofi gsk covid vaccine delayed until end of 2021 was published today ( ) and is available onsamanews ( palestine ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Sanofi, GSK Covid vaccine delayed until end of 2021 )